Shir A, Ogris M, Wagner E, Levitzki A (2006) EGF Receptor-Targeted Synthetic Double-Stranded RNA Eliminates Glioblastoma, Breast Cancer, and Adenocarcinoma Tumors in Mice. PLoS Med 3(1): e6. doi:10.1371/journal.pmed.0030006
After this article was published, we were alerted by a reader to a potential problem with Figure 6B. Subsequent investigation determined that this figure is indeed incorrect.
Figure 6. In Vivo Selectivity of the Approach
(B) Poly IC induces apoptosis in intracranial xenografts. Intracranial tumors were established and treated as described in Methods. Apoptotic death was detected using Cell Death Detection kit-TMR Red (Methods).doi:10.1371/journal.pmed.0040266.g001
The two lower panels come from the same tumor rather than different tumors as indicated in the legend. The authors have provided the correct figure, substituting images of samples taken from different tumors from the same experiment.
The authors regret this error and are willing to provide all reagents necessary to repeat the experiment in question to interested scientists. Requests for reagents should be addressed directly to the corresponding author at firstname.lastname@example.org.
Citation: Shir A, Ogris M, Wagner E, Levitzki A (2007) Correction: EGF Receptor-Targeted Synthetic Double-Stranded RNA Eliminates Glioblastoma, Breast Cancer, and Adenocarcinoma Tumors in Mice. PLoS Med 4(8): e266. doi:10.1371/journal.pmed.0040266
Received: July 23, 2007; Accepted: July 23, 2007; Published: August 28, 2007
Copyright: © 2007 Shir et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.